Literature DB >> 22764759

Emerging personalized oncology: sequencing and systems strategies.

William Cho, Demosthenes E Ziogas, Christos Katsios, Dimitrios H Roukos.   

Abstract

Mesh：

Year:  2012        PMID： 22764759     DOI： 10.2217/fon.12.44

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  11 in total

1.  Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma.

Authors:  Jian Yin; Peng Hou; Zhiqiang Wu; Tao Wang; Yanxiao Nie
Journal:  Tumour Biol       Date:  2015-01-25

Review 2.  miRNAs: new tools for molecular classification, diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Angela M Liu; Wei Wang; John M Luk
Journal:  Hepat Oncol       Date:  2014-09-09

3.  Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma.

Authors:  Jian-Wei Zhang; Tao Qin; Shao-Dong Hong; Jing Zhang; Wen-Feng Fang; Yuan-Yuan Zhao; Yun-Peng Yang; Cong Xue; Yan Huang; Hong-Yuan Zhao; Yu-Xiang Ma; Zhi-Huang Hu; Pei-Yu Huang; Li Zhang
Journal:  Chin J Cancer       Date:  2015-04-08

4.  Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy.

Authors:  Kai Zhu; Zhi Dai; Jian Zhou
Journal:  Biomark Res       Date:  2013-02-05

Review 5.  Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention.

Authors:  Wafaa M Ezzat; Khalda Sayed Amr
Journal:  World J Hepatol       Date:  2016-10-28

Review 6.  Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers.

Authors:  Amit Kumar Singh; Ramesh Kumar; Abhay K Pandey
Journal:  Curr Chem Genom Transl Med       Date:  2018-06-29

7.  Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Kai Zhu; Hao Zhan; Yuanfei Peng; Liuxiao Yang; Qiang Gao; Hao Jia; Zhi Dai; Zhaoyou Tang; Jia Fan; Jian Zhou
Journal:  Carcinogenesis       Date:  2020-05-14       Impact factor: 4.944

8.  Identification of Novel Gene Signature Associated with Cell Glycolysis to Predict Survival in Hepatocellular Carcinoma Patients.

Authors:  Ming Wang; Feng Jiang; Ke Wei; Erli Mao; Guoyong Yin; Chuyan Wu
Journal:  J Oncol       Date:  2021-05-06       Impact factor: 4.375

Review 9.  Personalized targeted therapy for lung cancer.

Authors:  Kehua Wu; Larry House; Wanqing Liu; William C S Cho
Journal:  Int J Mol Sci       Date:  2012-09-13       Impact factor: 6.208

Review 10.  [Personalized targeted therapy for lung cancer].

Authors:  Kehua Wu; Larry House; Wanqing Liu; William C S Cho
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.